1 Healthcare Stock with Competitive Advantages and 2 We Brush Off

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 3.7% has lagged the S&P 500’s 7.1% climb.